Concepedia

Paul Balbo

PB

13

Publications

1.2K

Citations

12

H-Index

1998

Active since

Affiliations

Pfizer (United States)(Current)

Tufts University

University of Kentucky

Paul Balbo is an author at Pfizer (United States) specializing in medicine, drug discovery, and pharmacology.

Top concepts

Publications per year

1998–2020

13

Publications

13

<i>Campylobacter jejuni</i> Cytolethal Distending Toxin Causes a G <sub>2</sub> -Phase Cell Cycle Block

Chris A. Whitehouse, Paul Balbo, Everett C. Pesci et al. · Infection and Immunity · 1998 · 254 citations · Full text

Discovery of a JAK3-Selective Inhibitor: Functional Differentiation of JAK3-Selective Inhibition over pan-JAK or JAK1-Selective Inhibition

Jean‐Baptiste Telliez, Martin E. Dowty, Lu Wang et al. · ACS Chemical Biology · 2016 · 187 citations · Full text

, , +30

Yersiniabactin from Yersinia pestis: biochemical characterization of the siderophore and its role in iron transport and regulation

Robert D. Perry, Paul Balbo, Heather Jones et al. · Microbiology · 1999 · 175 citations

, , +16

Design of a Janus Kinase 3 (JAK3) Specific Inhibitor 1-((2<i>S</i>,5<i>R</i>)-5-((7<i>H</i>-Pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one (PF-06651600) Allowing for the Interrogation of JAK3 Signaling in Humans

Atli Thorarensen, Martin E. Dowty, Mary Ellen Banker et al. · Journal of Medicinal Chemistry · 2017 · 158 citations · Full text

, , +25

Mechanism of Poly(A) Polymerase: Structure of the Enzyme-MgATP-RNA Ternary Complex and Kinetic Analysis

Paul Balbo, Andrew Bohm · Structure · 2007 · 90 citations · Full text

Rows per page

1–5 of 13